Skip to main content
BMB Reports logoLink to BMB Reports
. 2019 Jan 31;52(1):13–23. doi: 10.5483/BMBRep.2019.52.1.300

Mitochondria: multifaceted regulators of aging

Jyung Mean Son 1, Changhan Lee 1,2,3,*
PMCID: PMC6386233  PMID: 30545443

Abstract

Aging is accompanied by a time-dependent progressive deterioration of multiple factors of the cellular system. The past several decades have witnessed major leaps in our understanding of the biological mechanisms of aging using dietary, genetic, pharmacological, and physical interventions. Metabolic processes, including nutrient sensing pathways and mitochondrial function, have emerged as prominent regulators of aging. Mitochondria have been considered to play a key role largely due to their production of reactive oxygen species (ROS), resulting in DNA damage that accumulates over time and ultimately causes cellular failure. This theory, known as the mitochondrial free radical theory of aging (MFRTA), was favored by the aging field, but increasing inconsistent evidence has led to criticism and rejection of this idea. However, MFRTA should not be hastily rejected in its entirety because we now understand that ROS is not simply an undesired toxic metabolic byproduct, but also an important signaling molecule that is vital to cellular fitness. Notably, mitochondrial function, a term traditionally referred to bioenergetics and apoptosis, has since expanded considerably. It encompasses numerous other key biological processes, including the following: (i) complex metabolic processes, (ii) intracellular and endocrine signaling/communication, and (iii) immunity/inflammation. Here, we will discuss shortcomings of previous concepts regarding mitochondria in aging and their emerging roles based on recent advances. We will also discuss how the mitochondrial genome integrates with major theories on the evolution of aging.

Keywords: Aging, Communication, Mitochondria, Mitochondrial DNA, Signaling

INTRODUCTION

Mitochondria are unique cellular organelles in that they inherently possess their own genome in the form of a circular DNA (mitochondrial DNA; mtDNA) which presumably derived from endosymbiotic alpha-proteobacteria. Traditionally, the main function of mitochondria has been considered to be ATP production by oxidative phosphorylation. However, recently, mitochondria have been increasingly appreciated as a major hub that transmits adaptive regulatory signals to control a wide range of cellular functions, including immunity, survival, and homeostasis, with strong implications in aging. Mitochondria regulate many age-related pathways including senescence, unfolded protein response (UPR), autophagy, and inflammation. Some prominent pathways include the following: (i) reactive oxygen species (ROS) signaling that have a broad cellular impact including nuclear gene regulation, (ii) mitochondrial unfolded response (UPRmt) whereby mitochondrial perturbations activate stress-responsive transcriptional responses in the nucleus via factors such as activating transcription factor associated with stress-1 (ATFS-1) in C. elegans and ATF-5 in mammals, (iii) metabolite signaling, (iv) mitochondrial damage-associated molecular patterns (mtDAMPs) that consist of molecules released from injured mitochondria, and (v) mitochondrial-derived peptides (MDPs) that are factors encoded within the mtDNA.

Notably, mitochondrial communication is an emerging biology with increasing evidence for a key role in normal aging and age-related disease, but the mechanistic details are largely unclear. In this review, we will discuss mitochondrial communication, with an emphasis on its influences on cellular function, homeostasis, and aging.

MITOCHONDRIAL GENOMIC INSTABILITY AND AGING

Several theories have been proposed to unravel the biological basis of aging. The mitochondrial free radical theory of aging (MFRTA) has been a prominent concept that describes mitochondria as a major driving force of aging. First proposed by Denham Harman in the 1950s, the theory posits that the progressive accumulation of cellular damages inflicted by free radicals generated during mitochondrial metabolism leads to aging (1, 2). However, MFRTA has been increasingly unfavored because of inconsistent data that suggest alternative mitochondrial contributions to aging. Here, we will discuss the past, present, and future of the role of mitochondria in lifespan and healthspan.

Free radicals are molecules with at least one unpaired electron. During mitochondrial oxidative phosphorylation, electrons can ‘leak’ to form free radicals that react with surrounding oxygen to generate reactive oxygen species (ROS), which in turn can damage cellular macromolecules such as lipids, protein, and DNA. Mitochondrial DNA (mtDNA), due to its proximity to the site of ROS production, was thought to be highly vulnerable (3). In addition, a contemporary notion that the mitochondrial DNA repair system was inferior to the nuclear counterpart provided added support to MRFTA (4). However, mtDNA integrity is maintained at multiple levels, including a repair system that is more versatile than previously thought (5), physical shielding by nucleoids (6, 7), mitochondrial fission and fusion (8, 9), and mitophagy (10). Nonetheless, mtDNA mutation frequency increases with age in various animal models and humans (1114), although their role as the driver of aging has been unclear (15, 16). A mutation load greater than 60%–90%, which is beyond what is incurred by aging, has been suggested to be necessary for age-related phenotypes to manifest (1719).

Genetic manipulations of the antioxidant system intended to test MFRTA (i.e., the role of ROS in aging) more directly has been inconsistent and inconclusive (20). Only some cellular antioxidant systems that were inactivated shortened lifespan in yeast [i.e. copper-zinc superoxide dismutase (CuZnSOD; sod1), manganese superoxide dismutase (MnSOD; sod2), and copper chaperone (ccs1)] (21, 22), worms (sod isoforms) (23), flies (sod1 and sod2) (2427), and mice (i.e. sod1) (28). Notably, many antioxidant genes did not significantly affect lifespan in these model organisms. On the contrary, it has been shown that overexpression of antioxidant components including sod1 and sod2 can increase lifespan in yeast (29), worms (30, 31), and flies (3234). In mice, it has been shown that overexpression of human catalase localized to mitochondria (mCAT) can decrease oxidative stress and extend lifespan (35). It can also improve age-dependent insulin resistance (36). One caveat of the report by Schriner et al. (35) was that lifespan extension was significant in mCAT mice that were two to four generations backcrossed to the C57BL/6J strain. However, the longevity effect diminished after > 9 generations. This could be a secondary effect derived from epistasis and/or CMV element methylation (37).

Perhaps the most direct challenge to MFRTA comes from the failure to detect age-dependent increase in ROS-induced mtDNA damage. DNA mutations that arise from ROS can cause an 8-oxo-2′-deoxyguanosine (8-oxodG)-mediated G-to-T transversion (38). However, mtDNA mutations in brain and heart of old mice (> 24 mo. vs < 10 months) were transitions whereas G-to-T transversions were modest (39). Notably, transitions are mostly caused by replicative infidelity (i.e., DNA polymerase errors), indicating that replicative errors, not ROS, are the main culprit of age-dependent mtDNA mutations. In addition, ultra-deep hepatic mtDNA sequencing showed increased age-dependent replicative errors, not ROS-dependent damage (40). Similarly, highly sensitive duplex sequencing of aged human pre-frontal cortex mtDNA (> 75 yrs vs. < 1 yr) revealed higher proportions of replication errors rather than oxidative damage (41).

Inactivating the proofreading activity of mitochondrial-specific DNA polymerase γ (mtDNA mutator in mice) by targeted mutagenesis at amino acid position 257 (D257A) increased mtDNA mutation frequency to supraphysiological levels in mice: ~2,500-fold and ~500-fold higher in homozygous (polgmut/mut) and heterozygous (polg+/mut) mutant mice, respectively (39). Although homozygous (polgmut/mut) mice exhibited accelerated aging phenotypes and significantly reduced lifespan, heterozygous (polg+/mut) mice did not show early signs of aging. They had a normal lifespan (39, 42). Furthermore, mtDNA mutator mice exhibited OXPHOS dysfunction without significant increase of oxidative damage (4345). Notably, ROS levels in young mtDNA mutator mice were not increased despite high levels of mtDNA mutations (46). Nonetheless, these mutations have been implicated in more than 300 diseases that are linked to aging and age-related diseases listed in the Human DNA Polymerase Gamma Mutation Database (http://tools.niehs.nih.gov/polg) (47). Lastly, mtDNA deletions that become prevalent with aging (4850) are significantly increased in short-lived homozygous (polgmut/mut) mice, but not in heterozygous (polg+/mut) mice that had a normal lifespan (51). These results suggest a more complicated connection between mtDNA mutation frequency and aging. Further investigations are needed to identify other aspects of mtDNA mutator mice such as mitochondrial communication.

CELL-AUTONOMOUS MITOCHONDRIAL COMMUNICATION AND AGING

Eukaryotic cells are functionally compartmentalized into organelles with assigned distinct tasks that work in concert. Such subcellular coordination is mediated by inter-organellar communication to maintain cellular homeostasis. The mechanism underlying inter-organellar communication is an emerging topic in biology that has much implications for aging. On that line, the connection between mitochondria and the nucleus is of special interest considering that they uniquely possess independent genomes (Fig. 1A).

Fig. 1.

Fig. 1

Mitochondrial Communication Modes. (A) Mitochondria communicate to the nucleus and other cells (i.e., mitochondrial endocrine signaling) using various mediators such as ROS, UPRmt, DAMPs, and mitochondrial-encoded MDPs. (B) Mitochondria also communicate with other organelles (e.g., endoplasmic reticulum, lysosomes, and peroxisomes) to coordinate complex cellular processes.

Mitonuclear communication

Mitochondria presumably originate from α-proteobacteria that have sustained an endosymbiotic relationship with our ancestral cells ~1.5 billion years ago. Notably, mitochondrial retained a portion of the original bacterial genomes that co-evolved with nuclear genome. However, mitochondria import over a thousand proteins encoded in the nuclear genome to maintain their diverse functions, reflecting their close relationship. Therefore, it is critical that mitochondria and the nucleus dynamically communicate (i.e., mitonuclear communication) with each other to coordinate adaptive responses to the constantly changing intrinsic and extrinsic cellular milieu and maintain homeostasis. In fact, impaired mitonuclear communication is strongly implicated in aging and age-dependent diseases. Mitonuclear communication is bi-directional. It is mediated by several factors transmitted from each organelle. In this review, we will focus on signals transmitted from mitochondria to the nucleus (i.e., retrograde signals), including reactive oxygen species (ROS), mitochondrial unfolded protein response (UPRmt), metabolites, mitochondrial damage-associated molecular patterns (mtD AMP), and mitochondrial derived peptides (MDPs).

Reactive Oxygen Species (ROS) signaling

ROS is often considered as a toxic metabolic byproduct that causes detrimental damage to multiple cellular components, thereby contributing to the aging process (3, 52). However, as discussed above, mitochondrial ROS is not the major cause of mtDNA mutations, indicating a more complex cellular role. Actions of ROS are pleiotropic. They cause oxidative stress at higher concentrations (pathological) while they act as signaling molecules at lower levels (physiological). In fact, physiological ROS response has been suggested as eustress (53) that increases mitohormesis as an adaptive response to promote health and extend lifespan (54). Increasing interest in ROS as signaling molecules that regulate normal physiological processes has provided insight into its role in regulating lifespan and/or healthspan (53, 55, 56). In fact, lifespan extension in various model organisms such as worm, fly, and mice is mediated by retrograde ROS. In worms, RNAi screens have identified long-lived animals that harbor mutations in mitochondrial respiration (57, 58). On that line, retrograde ROS signaling can mediate lifespan extension in worms with impaired insulin/IGF-1 signaling while inhibition of ROS signals using antioxidants can reduce such longevity by up to 60% (59). Furthermore, a mild increase in ROS levels by inhibiting respiration can activate transcription factor hypoxia-inducible factor 1 (HIF-1) and consequent nuclear gene expression to promote longevity in worms (60). In addition to modulating factors, ROS can also lead to epigenetic alternations (61, 62). For instance, ROS can regulate the chromatin binding capacity of histone demethylase Rph1p, thereby extending chronological lifespan in yeast (63). Moreover, ROS can promote mitochondrial unfolded protein response (UPRmt). This will be further discussed in the following section.

Mitochondrial unfolded protein response (UPRmt)

Mitochondrial unfolded protein response (UPRmt) is a mitochondria-to-nuclear communication mechanism that promotes adaptive regulation of nuclear genes related to mitochondrial chaperones, proteases, antioxidants, xenobiotic response, and metabolism, ultimately rewiring the cell to survive. UPRmt was initially thought to be triggered by mtDNA depletion or by protein misfolding in the mitochondrial matrix (64). However, it now encompasses various mitochondrial stress conditions, including dysfunctional metabolism, defective iron sulfur cluster assembly, and immune response (64, 65). The activating transcription factor associated with stress 1 (ATFS-1) in worms is a major mediator of UPRmt. Normally, ATFS-1 is imported into mitochondria for proteolytic degradation. However, mitochondrial stress will trigger ATFS-1 to translocate from mitochondria to the nucleus where it regulates the expression of a considerable portion of mitochondrial stress-responsive genes (65, 66). Such bi-organellar trafficking to coordinate mitonuclear communication is possible because ATFS-1 possesses both a mitochondrial-targeting sequence (MTS) and a nuclear localization signal (NLS) (65, 66). ATFS-1 also plays a role in chromatin remodeling which is required for full activation of UPRmt via the histone methyltransferase met-2 and a nuclear co-factor lin-65 to promote longevity (67). CLOCK-1 (CLK-1; human homolog COQ7) acts as a ROS barometer that mediates mitochondria to nuclear signaling by activating UPRmt. clk-1 null worms have extended lifespans (68). Such effect appears to be mediated by UPRmt (66). In mice, the loss of clk1 also increases cellular fitness and lifespan (69).

Metabolite signaling

Mitochondria are metabolic hubs that perform a wide range of catabolic and anabolic processes, thereby generating a variety of metabolites. Mitochondrial metabolites can also act as secondary messengers for genetic or epigenetic regulation (70, 71). Of these metabolites, many are products of the tricarboxylic acid (TCA) cycle, such as acetyl-coenzyme A (acetyl-CoA), succinyl-CoA, and nicotinamide adenine dinucleotide (NAD+). The pyruvate dehydrogenase (PDH) complex that normally resides in mitochondria and generates acetyl-coenzyme A (acetyl-CoA) can translocate from mitochondria to the nucleus where it is involved in producing acetyl-CoA in the nucleus and modulate histone acetylation which requires acetyl-CoA as a substrate for lysine acetylation (72, 73). Under growth conditions, acetyl-CoA levels are higher in the nucleus and cytosol for lipid synthesis and histone acetylation. However, under starvation conditions, acetyl-CoA predominantly resides in mitochondria for ATP and ketone body production (74). Succinyl-CoA is another TCA cycle intermediate that can post-translationally modify proteins by succinylating lysine residues of proteins (75) such as histones, thereby affecting chromatin dynamics and consequently the epigenome (76). In a similar way, other TCA intermediates, including oxaloacetate, malate, fumarate and α-ketoglutarate, can also induce genetic and epigenetic reprogramming and extend worm lifespan (77). NAD+ is also a crucial mitochondrial gero-metabolite that declines with age (78, 79). Reduced age-dependent NAD+ availability is linked to decreased deacetylase sirtuin activities, ultimately affecting the communication between mitochondria and nucleus (80, 81). It also affects longevity (82, 83). Retrograde Ca2+ is another important inorganic gero-metabolite (84). Nuclear skeletal muscle gene expression is regulated by mitochondrial Ca2+ which mediates mitochondria to nucleus route (85).

Mitochondrial damage-associated molecular patterns (mtDAMP)

Our immune system becomes progressively impaired with age, leading to the loss of immune function (i.e., immunosenescence) and elevated chronic low-grade inflammation (i.e., inflammaging) (86). Immune responses can be triggered not only by foreign materials/organisms, but also by endogenous factors. Pathogen-associated molecular patterns (PAMPs) derived from bacteria, fungi, and viruses can induce innate immune responses via inflammasomes that are intracellular complexes capable of promoting pro-inflammatory cytokines such as interleukin-1β (IL-1β) and IL-18 (87). Damage-associated molecular patterns (DAMPs) derived from endogenous intracellular components that are released during cellular stress and/or damage can also mount an immune response (88). Especially, injured mitochondria can release their contents known as mitochondrial damage-associated molecular patterns (mtDAMP) recognized as PAMPs owing to their bacterial ancestry. Some well described mtDAMPs include mtDNA, N-formyl peptides (specific to mitochondrially-translated proteins), and fragments of mitochondrial proteins (89, 90). The innate immune system can express pro-inflammatory cytokines upon sensing circulating mtDNA and N-formyl peptides using pattern recognition receptors (PRR) such as toll-like receptors (TLRs) and NOD-like receptors (NLRs) (90). Notably, circulating mtDNA levels are increased with age. Their increase is associated with elevated levels of cytokines and inflammatory markers, indicating a role of mtDNA in inflammaging (91) and may contribute to the development of age-related diseases (92, 93).

Mitochondrial-derived peptides (MDPs)

The human mtDNA encodes only 13 protein-coding genes that are all structural components of the electron transport chain (ETC) without known signaling roles. Thus, active gene-encoded mitonuclear communication pathways were known to be exclusively mediated by factors encoded in the nuclear genome. More recently, short open reading frames (sORFs) encoded in the mitochondrial genome that yield bioactive peptides, collectively referred to as mitochondrial-derived peptides (MDPs), have been identified (94). There are now eight published MDPs, including humanin, MOTS-c (mitochondrial open reading frame of the twelve S rRNA type-c), and small humanin-like peptide (SHLP) 1-6. They regulate various cellular functions. Humanin is encoded within the mitochondrial 16S rRNA. It was identified from a surviving brain fraction of an Alzheimer’s disease (AD) patient as a protective factor against AD-related toxins such as β-amyloid (95). It is also a binding partner of insulin-like growth factor binding protein 3 (IGFBP-3) (96) and an anti-apoptotic factor that inhibits Bax (97). SHLP 1-6 were also identified within the 16S rRNA (98). MOTS-c is encoded within the mitochondrial 12S rRNA. It acts as a regulator of metabolic homeostasis that can prevent diet-induced obesity and insulin resistance, and age-dependent insulin resistance in mice (99101). Notably, MOTS-c can translocate to the nucleus upon cellular stress to regulate adaptive nuclear gene expression by interacting with other stress-responsive transcription factors including nuclear factor erythroid 2-related factor 2 (NFE2L2/NRF2) and binding to chromatin (102104). HEK293 cells that over-express MOTS-c were significantly protected against metabolic stress (i.e., glucose and serum deprivation) (102). This indicates that our co-evolved mitonuclear genomes have established a genetically integrated bi-directional communication system.

Humanin, SHLP2, and MOTS-c levels decline with age and their actions are positively correlated with longevity (94, 98, 100, 105). Humanin levels are negatively regulated by the GH/IGF axis in both mice and humans (106). Circulating humanin levels are elevated in long-lived GH-deficient Ames mice, but decreased in short-lived GH-transgenic mice (106). MOTS-c can reverse age-dependent insulin resistance. A functional MOTS-c polymorphism is related to exceptional longevity in a Japanese population (107, 108). Furthermore, MOTS-c actions are, in part, dependent on sirtuin 1 (SIRT1) and AMPK (100, 102), two prominent related factors shown to regulate longevity in various model organisms (109, 110).

Because of the unique bi-genomic cellular setup, it is important to consider mitonuclear epistasis. mtDNA is maternally transmitted, which forces a cell to coordinate gene expression with a foreign (i.e., paternal) genome upon fertilization. The compatibility between maternal mtDNA and paternal nuclear DNA is a major ground for intergenomic epistasis (111113). Nuclear gene expression is dependent on the mtDNA background. Nuclear mutations can manifest very differently under varying mtDNA context. For instance, patients with a mutation in the adenine nucleotide translocator 1 gene (SLC25A4, ANT1) exhibit a wide range of cardiomyopathies that are correlated with their mtDNA lineage (114). In 2015, the United Kingdom approved mtDNA replacement therapy to allow a woman to transfer her nuclear genome to an egg with healthy mitochondria to prevent transmission of mtDNA disease (so-called three-parent baby). Such forced mtDNA-nDNA combinations may be incompatible. It can cause dysregulated mitonuclear communication (Hamilton 2015). In fact, alloantigenicity and immune rejection have been documented in nuclear-transfer-derived embryonic stem cells (NT-ESCs) (115). In addition, Mitochondrial-Nuclear eXchange (MNX) mice with interchanged nuclear and mitochondrial genomes from different mice (similar to three-parent baby) have differential oxidative stress, resistance to heart failure, lipid concentration, and bioenergetics (116, 117). Aging is a complex process with strong genetic components. It is likely to be dependent on both of our genomes. Thus, the interaction between factors encoded in each genome may further our understanding of aging genetics.

Other mito-organellar communication

Cellular functions are compartmentalized into various organelles with unique roles. Their orchestrated processes together support survival. Therefore, inter-organellar communication is key to cellular homeostasis and ultimately organismal fitness. On that line, mitochondria not only communicate with the nucleus, but also dynamically interact with other organelles (118) (Fig. 1B). Although the field of inter-organellar communication is still in its early stages, it is undoubtedly of great interest. Further investigation of mito-organellar communication with high spatial and temporal resolution and identification of key signaling mediators are necessary to understand the complex coordination of subcellular processes and their roles in aging. Here, we will focus on mitochondrial communication with the ER, peroxisomes, and lysosomes in the context of aging.

Mitochondria and Endoplasmic Reticulum (ER) Communication

The ER physically interacts with mitochondria to regulate organelle morphology and various metabolic signaling (119). The contact sites that ER forms with mitochondria are called mitochondria-associated membranes (MAM), which have numerous roles in controlling lipid and calcium homeostasis, mitochondrial metabolism, insulin and glucose signaling, and ultimately aging (120). Proteome analysis of MAM has revealed its connection to various age-related diseases, such as Alzheimer’s disease and type 2 diabetes (120). Cisd2 knockout mice also provide evidence that MAM may play a role in aging. Cisd2 is a regulator of intracellular Ca2+ and glucose homeostasis that localizes to the ER, mitochondrial membranes, and MAM (121). Mice that lacked Cisd2 showed mitochondrial degeneration and functional decline in skeletal muscle and neurons, glucose intolerance, premature aging phenotypes (e.g. ocular degeneration, dermal deterioration, sarcopenia, etc.), and shortened lifespan (122), implying that disruption of mitochondria and ER communication could affect the aging process.

Mitochondria and Peroxisome Communication

Increasing evidence points to the mitochondrial-peroxisomal connection as an important aspect of aging and age-related disease (123, 124). Restoring the import of peroxisomal catalase which decomposes hydrogen peroxide can restore mitochondrial integrity and reverse the senescent phenotype of human fibroblasts (125). Another study demonstrated that peroxisome proliferation and higher peroxisomal antioxidant activity can regulate the aging of hippocampal neurons (126, 127). Furthermore, the three-way communication among mitochondria, peroxisome, and ER may contribute to the aging process by fine-tuning redox and ion signaling pathways (128). Redox-regulatory enzymes can assemble at the “redox triangle” created by these three organelles to sense ROS accumulations and redox imbalances. The redox triangle may become dysfunctional with age (128). However, further investigations on the mechanistic details regarding the multidirectional communication among mitochondria, ER, and peroxisome and their roles in aging are needed.

Mitochondria and Lysosome Communication

Lysosomes are subcellular sites of protein turnover and metabolite storage. Its dysfunction is linked to aging and age-associated diseases (129). Mito-lysosomal communication is mediated by physical contact, lipids, and metabolite exchange (130). In yeast, lysosome-like vacuoles are functionally linked to mitochondria. Increased vacuolar pH gives rise to age-dependent mitochondrial dysfunction (131), indicating that mito-lysosomal communication is important for organismal homeostasis and lifespan. In addition, the contact site between mitochondria and yeast lysosome-like vacuoles known as vCALMP (vacuole and mitochondria patch) is enriched with ion and amino acid transporters. It is important for lipid exchange between the two organelles (132). Furthermore, the inter-organellar lipid homeostasis coordinated among mitochondria, lysosomes, and ER [ER-mitochondria encounter structure (ERMES)) may be important in aging (132, 133). This is also supported by Ltc1 (lipid transfer at contact site 1), a sterol-dependent regulator of organelle and cellular homeostasis via its dual localization to ER-mitochondria and ER-vacuole contact sites (134). It is especially important in nutrient sensing and signaling (135) as well as replicative aging in yeast (131).

NON-CELL AUTONOMOUS MITOCHONDRIAL COMMUNICATION AND AGING

Mitochondrial communication is not confined to intracellular coordination. Recent studies have shown that mitochondria can also transmit signals to distal cells of different tissues as described in this section. Such non-cell autonomous mitochondrial signals are often referred as mitochondrial cytokines (mitokines) or mitochondrial hormones. The evolutionary aspect of intra-organ mitochondrial communication is interesting in that they may represent an archaic endocrine system. Non-cell autonomous mitochondrial signals provide another layer of endocrine regulation of longevity (Fig. 1A).

Mitokines

The connection between UPRmt and longevity has been investigated in mutant worms with perturbed mitochondrial ETC (e.g., cco-1 knockdown) that exhibited extended lifespan (136). Interestingly, cco-1 knockdown in neurons activated UPRmt in the intestine, indicating a soluble factor that could relay signals between distal tissues, dubbed mitokine (136, 137). In addition, Wnt signaling may be a mitokine in worms (138). Neuronal expression of the Wnt ligand/EGL-20 in worms activated cell-non-autonomous UPRmt that required orchestrated actions of a retromer complex, Wnt signaling, and serotonin (138). In flies, mild ETC disruption in muscles prolonged lifespan through UPRmt and insulin signaling (140). In mice, fibroblast growth factor 21 (Fgf21) has also been proposed as a mitokine because its production by muscle cells can trigger mitochondrial biogenesis, browning of white adipose tissue (WAT), and increase lipid oxidation (140). These results support the existence of systemic mitochondrial communication factors that can regulate longevity, including neurotransmitters and neuropeptides (141, 142). The scope of factors that can act as mitokines is likely to be broad.

Mitochondrial derived peptides (MDPs)

MDPs are found in circulation. They can act on certain tissues. Thus, they have been dubbed mitochondrial hormones (84, 143, 144). Circulating humanin levels are decreased with age in mice and humans (105, 106, 145). Humanin is integrated with the GH/IGF-1 axis which is the most prominent endocrine regulator of aging. Long-lived GH-deficient Ames mice showed higher circulating humanin levels whereas short-lived GH-transgenic mice had lower humanin levels compared to their wild type counterparts (106). Notably, an Ecuadorian cohort with GH receptor deficiency (GHRD) that have very low levels of IGF-I are exceptionally protected against cancer and diabetes (146). However, they showed 80% increase in circulating humanin levels compared to their unaffected relatives. These studies indicate a role for humanin as an endocrine regulator of aging that is tethered with the GH/IGF-1 axis. Similar to humanin, levels of circulating SHLP2 are also decreased with age, indicating its relevance to aging as a mitochondrial hormone (147). Plasma levels of MOTS-c are also decreased ~30% in old mice. Systemic injection of MOTS-c reversed age-dependent skeletal muscle insulin resistance in mice (100).

CONCLUSION

Mitochondria are versatile organelles that play roles in multiple cellular functions that ultimately affect organismal fitness and lifespan/healthspan. The multifaceted nature of mitochondria indicates its complex roles in aging and age-related diseases. Thus, it is imperative to investigate how mitochondria contribute, and even drive, aging with a comprehensive and holistic approach. The silver lining of the downfall of MFRTA is that dynamic expansion of concepts and experimental data have continued to reveal the complexity and breadth of mitochondria in aging and age-related diseases.

ACKNOWLEDGEMENTS

This work was funded by grants from NIH (R01AG052558), the Ellison Medical Foundation, the American Federation for Aging Research (AFAR), and the Hanson-Thorell family to C.L., and an American Federation for Aging Research (AFAR) fellowship to J.M.S.

Footnotes

CONFLICTS OF INTEREST

C.L. is a consultant for and a shareholder of CohBar, Inc. The remaining authors declare no competing interests.

REFERENCES

  • 1.Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300. doi: 10.1093/geronj/11.3.298. [DOI] [PubMed] [Google Scholar]
  • 2.Harman D. Origin and evolution of the free radical theory of aging: a brief personal history, 1954–2009. Biogerontology. 2009;10:773. doi: 10.1007/s10522-009-9234-2. [DOI] [PubMed] [Google Scholar]
  • 3.Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc. 1972;20:145–147. doi: 10.1111/j.1532-5415.1972.tb00787.x. [DOI] [PubMed] [Google Scholar]
  • 4.Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A. 1997;94:514–519. doi: 10.1073/pnas.94.2.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kazak L, Reyes A, Holt IJ. Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol. 2012;13:659–671. doi: 10.1038/nrm3439. [DOI] [PubMed] [Google Scholar]
  • 6.Kang D, Kim SH, Hamasaki N. Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion. 2007;7:39–44. doi: 10.1016/j.mito.2006.11.017. [DOI] [PubMed] [Google Scholar]
  • 7.Lee SR, Han J. Mitochondrial nucleoid: shield and switch of the mitochondrial genome. Oxid Med Cell Longev. 20172017 doi: 10.1155/2017/8060949. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chen H, Vermulst M, Wang YE, et al. Mitochondrial Fusion Is Required for mtDNA Stability in Skeletal Muscle and Tolerance of mtDNA Mutations. Cell. 2010;141:280–289. doi: 10.1016/j.cell.2010.02.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Prevost CT, Peris N, Seger C, et al. The influence of mitochondrial dynamics on mitochondrial genome stability. Curr Genet. 2018;64:199–214. doi: 10.1007/s00294-017-0717-4. [DOI] [PubMed] [Google Scholar]
  • 10.Pickles S, Vigié P, Youle RJ. Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance. Curr Biol. 2018;28:R170–R185. doi: 10.1016/j.cub.2018.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res. 1990;18:6927–6933. doi: 10.1093/nar/18.23.6927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Piko L, Hougham AJ, Bulpitt KJ. Studies of sequence heterogeneity of mitochondrial DNA from rat and mouse tissues: evidence for an increased frequency of deletions/additions with aging. Mech Ageing Dev. 1988;43:279–293. doi: 10.1016/0047-6374(88)90037-1. [DOI] [PubMed] [Google Scholar]
  • 13.Larsson NG. Somatic mitochondrial DNA mutations in mammalian aging. Annu Rev Biochem. 2010;79:683–706. doi: 10.1146/annurev-biochem-060408-093701. [DOI] [PubMed] [Google Scholar]
  • 14.Payne BA, Wilson IJ, Yu-Wai-Man P, et al. Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet. 2013;22:384–390. doi: 10.1093/hmg/dds435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet. 1989;1:642–645. doi: 10.1016/S0140-6736(89)92145-4. [DOI] [PubMed] [Google Scholar]
  • 16.Khrapko K, Vijg J. Mitochondrial DNA mutations and aging: devils in the details? Trends Genet. 2009;25:91–98. doi: 10.1016/j.tig.2008.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rossignol R, Faustin B, Rocher C, Malgat M, Mazat JP, Letellier T. Mitochondrial threshold effects. Biochem J. 2003;370:751–762. doi: 10.1042/bj20021594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Stewart JB, Chinnery PF. The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nat Rev Genet. 2015;16:530–542. doi: 10.1038/nrg3966. [DOI] [PubMed] [Google Scholar]
  • 19.Kauppila TES, Kauppila JHK, Larsson NG. Mammalian Mitochondria and Aging: An Update. Cell Metab. 2017;25:57–71. doi: 10.1016/j.cmet.2016.09.017. [DOI] [PubMed] [Google Scholar]
  • 20.Pomatto LCD, Davies KJA. Adaptive homeostasis and the free radical theory of ageing. Free Radic Biol Med. 2018;124:420–430. doi: 10.1016/j.freeradbiomed.2018.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Unlu ES, Koç A. Effects of deleting mitochondrial antioxidant genes on life span. Ann N Y Acad Sci. 2007;1100:505–509. doi: 10.1196/annals.1395.055. [DOI] [PubMed] [Google Scholar]
  • 22.Longo VD, Gralla EB, Valentine JS. Superoxide dismutase activity is essential for stationary phase survival in Saccharomyces cerevisiae Mitochondrial production of toxic oxygen species in vivo. J Biol Chem. 1996;271:12275–12280. doi: 10.1074/jbc.271.21.12275. [DOI] [PubMed] [Google Scholar]
  • 23.Doonan R, McElwee JJ, Matthijssens F, et al. Against the oxidative damage theory of aging: superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans. Genes Dev. 2008;22:3236–3241. doi: 10.1101/gad.504808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kirby K, Hu J, Hilliker AJ, Phillips JP. RNA interference-mediated silencing of Sod2 in Drosophila leads to early adult-onset mortality and elevated endogenous oxidative stress. Proc Natl Acad Sci U S A. 2002;99:16162–16167. doi: 10.1073/pnas.252342899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Martin I, Jones MA, Rhodenizer D, et al. Sod2 knockdown in the musculature has whole-organism consequences in Drosophila. Free Radic Biol Med. 2009;47:803–813. doi: 10.1016/j.freeradbiomed.2009.06.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Duttaroy A, Paul A, Kundu M, Belton A. A Sod2 null mutation confers severely reduced adult life span in Drosophila. Genetics. 2003;165:2295–2299. doi: 10.1093/genetics/165.4.2295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wicks S, Bain N, Duttaroy A, Hilliker AJ, Phillips JP. Hypoxia rescues early mortality conferred by superoxide dismutase deficiency. Free Radic Biol Med. 2009;46:176–181. doi: 10.1016/j.freeradbiomed.2008.09.036. [DOI] [PubMed] [Google Scholar]
  • 28.Pérez VI, Bokov A, Van Remmen H, et al. Is the oxidative stress theory of aging dead? Biochim Biophys Acta. 2009;1790:1005–1014. doi: 10.1016/j.bbagen.2009.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Fabrizio P, Liou LL, Moy VN, et al. SOD2 functions downstream of Sch9 to extend longevity in yeast. Genetics. 2003;163:35–46. doi: 10.1093/genetics/163.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Cabreiro F, Ackerman D, Doonan R, et al. Increased life span from overexpression of superoxide dismutase in Caenorhabditis elegans is not caused by decreased oxidative damage. Free Radic Biol Med. 2011;51:1575–1582. doi: 10.1016/j.freeradbiomed.2011.07.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Melov S, Ravenscroft J, Malik S, et al. Extension of Life-Span with Superoxide Dismutase/Catalase Mimetics. Science. 2000;289:1567–1569. doi: 10.1126/science.289.5484.1567. [DOI] [PubMed] [Google Scholar]
  • 32.Curtis C, Landis GN, Folk D, et al. Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophilareveals a species-general network of aging and metabolic genes. Genome Biol. 2007;8:R262. doi: 10.1186/gb-2007-8-12-r262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Sun J, Folk D, Bradley TJ, Tower J. Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster. Genetics. 2002;161:661–672. doi: 10.1093/genetics/161.2.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Parkes TL, Elia AJ, Dickinson D, Hilliker AJ, Phillips JP, Boulianne GL. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nat Genet. 1998;19:171–174. doi: 10.1038/534. [DOI] [PubMed] [Google Scholar]
  • 35.Schriner SE, Linford NJ, Martin GM, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science. 2005;308:1909–1911. doi: 10.1126/science.1106653. [DOI] [PubMed] [Google Scholar]
  • 36.Lee HY, Choi CS, Birkenfeld AL, et al. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab. 2010;12:668–674. doi: 10.1016/j.cmet.2010.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Brooks AR, Harkins RN, Wang P, Qian HS, Liu P, Rubanyi GM. Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J Gene Med. 2004;6:395–404. doi: 10.1002/jgm.516. [DOI] [PubMed] [Google Scholar]
  • 38.Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003;17:1195–1214. doi: 10.1096/fj.02-0752rev. [DOI] [PubMed] [Google Scholar]
  • 39.Vermulst M, Bielas JH, Kujoth GC. Mitochondrial point mutations do not limit the natural lifespan of mice. Nat Genet. 2007;39:540–543. doi: 10.1038/ng1988. [DOI] [PubMed] [Google Scholar]
  • 40.Ameur A, Stewart JB, Freyer C, et al. Ultra-deep sequencing of mouse mitochondrial DNA: mutational patterns and their origins. PLoS Genet. 2011;7:e1002028. doi: 10.1371/journal.pgen.1002028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kennedy SR, Salk JJ, Schmitt MW, Loeb LA. Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damage. PLoS Genet. 2013;9:e1003794. doi: 10.1371/journal.pgen.1003794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Trifunovic A, Wredenberg A, Falkenberg M, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004;429:417–423. doi: 10.1038/nature02517. [DOI] [PubMed] [Google Scholar]
  • 43.Edgar D, Shabalina I, Camara Y, et al. Random point mutations with major effects on protein-coding genes are the driving force behind premature aging in mtDNA mutator mice. Cell Metab. 2009;10:131–138. doi: 10.1016/j.cmet.2009.06.010. [DOI] [PubMed] [Google Scholar]
  • 44.Kujoth GC, Hiona A, Pugh TD, et al. Mitochondrial DNA Mutations, Oxidative Stress, and Apoptosis in Mammalian Aging. Science. 2005;309:481–484. doi: 10.1126/science.1112125. [DOI] [PubMed] [Google Scholar]
  • 45.Trifunovic A, Hansson A, Wredenberg A, et al. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci U S A. 2005;102:17993–17998. doi: 10.1073/pnas.0508886102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Logan A, Shabalina IG, Prime TA, et al. In vivo levels of mitochondrial hydrogen peroxide increase with age in mtDNA mutator mice. Aging Cell. 2014;13:765–768. doi: 10.1111/acel.12212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.DeBalsi KL, Hoff KE, Copeland WC. Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases. Ageing Res Rev. 2017;33:89–104. doi: 10.1016/j.arr.2016.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Bua E, Johnson J, Herbst A, et al. Mitochondrial DNA-Deletion Mutations Accumulate Intracellularly to Detrimental Levels in Aged Human Skeletal Muscle Fibers. Am J Hum Genet. 2006;79:469–480. doi: 10.1086/507132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res. 1990;18:6927–6933. doi: 10.1093/nar/18.23.6927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Bender A, Krishnan KJ, Morris CM, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006;38:515–517. doi: 10.1038/ng1769. [DOI] [PubMed] [Google Scholar]
  • 51.Vermulst M, Wanagat J, Kujoth GC, et al. DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat Genet. 2008;40:392–394. doi: 10.1038/ng.95. [DOI] [PubMed] [Google Scholar]
  • 52.Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359–407. doi: 10.1146/annurev.genet.39.110304.095751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Sarsour EH, Kalen AL, Goswami PC. Manganese superoxide dismutase regulates a redox cycle within the cell cycle. Antioxid Redox Signal. 2014;20:1618–1627. doi: 10.1089/ars.2013.5303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Ristow M. Unraveling the truth about antioxidants: mitohormesis explains ROS-induced health benefits. Nat Med. 2014;20:709–711. doi: 10.1038/nm.3624. [DOI] [PubMed] [Google Scholar]
  • 55.Sun N, Youle RJ, Finkel T. The Mitochondrial Basis of Aging. Mol Cell. 2016;61:654–666. doi: 10.1016/j.molcel.2016.01.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Shadel GS, Horvath TL. Mitochondrial ROS signaling in organismal homeostasis. Cell. 2015;163:560–569. doi: 10.1016/j.cell.2015.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Lee SS, Lee RY, Fraser AG, Kamath RS, Ahringer J, Ruvkun G. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet. 2003;33:40–48. doi: 10.1038/ng1056. [DOI] [PubMed] [Google Scholar]
  • 58.Dillin A, Hsu AL, Arantes-Oliveira N, et al. Rates of behavior and aging specified by mitochondrial function during development. Science. 2002;298:2398–2401. doi: 10.1126/science.1077780. [DOI] [PubMed] [Google Scholar]
  • 59.Zarse K, Schmeisser S, Groth M, et al. Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal. Cell Metab. 2012;15:451–465. doi: 10.1016/j.cmet.2012.02.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Lee SJ, Hwang AB, Kenyon C. Inhibition of respiration extends C. elegans life span via reactive oxygen species that increase HIF-1 activity. Curr Biol. 2010;20:2131–2136. doi: 10.1016/j.cub.2010.10.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Munoz-Najar U, Sedivy JM. Epigenetic control of aging. Antioxid Redox Signal. 2011;14:241–259. doi: 10.1089/ars.2010.3250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Rando TA, Chang HY. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell. 2012;148:46–57. doi: 10.1016/j.cell.2012.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Schroeder EA, Raimundo N, Shadel GS. Epigenetic silencing mediates mitochondria stress-induced longevity. Cell Metab. 2013;17:954–964. doi: 10.1016/j.cmet.2013.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Shpilka T, Haynes CM. The mitochondrial UPR: mechanisms, physiological functions and implications in ageing. Nat Rev Mol Cell Biol. 2018;19:109–120. doi: 10.1038/nrm.2017.110. [DOI] [PubMed] [Google Scholar]
  • 65.Nargund AM, Fiorese CJ, Pellegrino MW, Deng P, Haynes CM. Mitochondrial and nuclear accumulation of the transcription factor ATFS-1 promotes OXPHOS recovery during the UPR mt. Mol Cell. 2015;58:123–133. doi: 10.1016/j.molcel.2015.02.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Nargund AM, Pellegrino MW, Fiorese CJ, Baker BM, Haynes CM. Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science. 2012;337:587–590. doi: 10.1126/science.1223560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Tian Y, Garcia G, Bian Q, et al. Mitochondrial Stress Induces Chromatin Reorganization to Promote Longevity and UPR(mt) Cell. 2016;165:1197–1208. doi: 10.1016/j.cell.2016.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Felkai S, Ewbank JJ, Lemieux J, Labbé JC, Brown GG, Hekimi S. CLK-1 controls respiration, behavior and aging in the nematode Caenorhabditis elegans. EMBO J. 1999;18:1783–1792. doi: 10.1093/emboj/18.7.1783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Liu X, Jiang N, Hughes B, Bigras E, Shoubridge E, Hekimi S. Evolutionary conservation of the clk-1-dependent mechanism of longevity: loss of mclk1 increases cellular fitness and lifespan in mice. Genes Dev. 2005;19:2424–2434. doi: 10.1101/gad.1352905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Frezza C. Mitochondrial metabolites: undercover signalling molecules. Interface Focus. 2017;7 doi: 10.1098/rsfs.2016.0100. 20160100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Sullivan LB, Gui DY, Vander Heiden MG. Altered metabolite levels in cancer: implications for tumour biology and cancer therapy. Nat Rev Cancer. 2016;16:680–693. doi: 10.1038/nrc.2016.85. [DOI] [PubMed] [Google Scholar]
  • 72.Menzies KJ, Zhang H, Katsyuba E, Auwerx J. Protein acetylation in metabolism—metabolites and cofactors. Nat Rev Endocrinol. 2016;12:43–60. doi: 10.1038/nrendo.2015.181. [DOI] [PubMed] [Google Scholar]
  • 73.Sutendra G, Kinnaird A, Dromparis P, et al. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell. 2014;158:84–97. doi: 10.1016/j.cell.2014.04.046. [DOI] [PubMed] [Google Scholar]
  • 74.Shi L, Tu BP. Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr Opin Cell Biol. 2015;33:125–131. doi: 10.1016/j.ceb.2015.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Choudhary C, Weinert BT, Nishida Y, Verdin E, Mann M. The growing landscape of lysine acetylation links metabolism and cell signalling. Nat Rev Mol Cell Biol. 2014;15:536–550. doi: 10.1038/nrm3841. [DOI] [PubMed] [Google Scholar]
  • 76.Xie Z, Dai J, Dai L, et al. Lysine succinylation and lysine malonylation in histones. Mol Cell Proteomics. 2012;11:100–107. doi: 10.1074/mcp.M111.015875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Benayoun BA, Pollina EA, Brunet A. Epigenetic regulation of ageing: linking environmental inputs to genomic stability. Nat Rev Mol Cell Biol. 2015;16:593–610. doi: 10.1038/nrm4048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Schultz MB, Sinclair DA. Why NAD+ Declines during Aging: It’s Destroyed. Cell Metab. 2016;23:965–966. doi: 10.1016/j.cmet.2016.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Camacho-Pereira J, Tarragó MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metab. 2016;23:1127–1139. doi: 10.1016/j.cmet.2016.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Imai S-I, Guarente L. It takes two to tango: NAD+ and sirtuins in aging/longevity control. NPJ Aging Mech Dis. 2016;2:16017. doi: 10.1038/npjamd.2016.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Gomes AP, Price NL, Ling AJ, et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155:1624–1638. doi: 10.1016/j.cell.2013.11.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Mouchiroud L, Houtkooper RH, Moullan N, et al. The NAD+/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell. 2013;154:430–441. doi: 10.1016/j.cell.2013.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Yoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice. Cell Metab. 2011;14:528–536. doi: 10.1016/j.cmet.2011.08.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Quiros PM, Mottis A, Auwerx J. Mitonuclear communication in homeostasis and stress. Nat Rev Mol Cell Biol. 2016;17:213–226. doi: 10.1038/nrm.2016.23. [DOI] [PubMed] [Google Scholar]
  • 85.Mammucari C, Gherardi G, Zamparo I, et al. The mitochondrial calcium uniporter controls skeletal muscle trophism in vivo. Cell Rep. 2015;10:1269–1279. doi: 10.1016/j.celrep.2015.01.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576–590. doi: 10.1038/s41574-018-0059-4. [DOI] [PubMed] [Google Scholar]
  • 87.Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29:707–735. doi: 10.1146/annurev-immunol-031210-101405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Wenceslau CF, McCarthy CG, Szasz T, et al. Mitochondrial damage-associated molecular patterns and vascular function. Eur Heart J. 2014;35:1172–1177. doi: 10.1093/eurheartj/ehu047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104–107. doi: 10.1038/nature08780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Grazioli S, Pugin J. Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases. Front Immunol. 2018;9:832. doi: 10.3389/fimmu.2018.00832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Pinti M, Cevenini E, Nasi M, et al. Circulating mitochondrial DNA increases with age and is a familiar trait: Implications for “inflamm-aging”. Eur J Immunol. 2014;44:1552–1562. doi: 10.1002/eji.201343921. [DOI] [PubMed] [Google Scholar]
  • 92.Furman D, Chang J, Lartigue L, et al. Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states. Nat Med. 2017;23:174–184. doi: 10.1038/nm.4267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576–590. doi: 10.1038/s41574-018-0059-4. [DOI] [PubMed] [Google Scholar]
  • 94.Kim SJ, Xiao J, Wan J, Cohen P, Yen K. Mitochondrially derived peptides as novel regulators of metabolism. J Physiol. 2017;595:6613–6621. doi: 10.1113/JP274472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Hashimoto Y, Niikura T, Tajima H, et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer’s disease genes and Abeta. Proc Natl Acad Sci U S A. 2001;98:6336–6341. doi: 10.1073/pnas.101133498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Ikonen M, Liu B, Hashimoto Y, et al. Interaction between the Alzheimer’s survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci U S A. 2003;100:13042–13047. doi: 10.1073/pnas.2135111100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Guo B, Zhai D, Cabezas E, et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature. 2003;423:456–461. doi: 10.1038/nature01627. [DOI] [PubMed] [Google Scholar]
  • 98.Cobb LJ, Lee C, Xiao J, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging. 2016;8:796–809. doi: 10.18632/aging.100943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Zarse K, Ristow M. A mitochondrially encoded hormone ameliorates obesity and insulin resistance. Cell Metab. 2015;21:355–356. doi: 10.1016/j.cmet.2015.02.013. [DOI] [PubMed] [Google Scholar]
  • 100.Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21:443–454. doi: 10.1016/j.cmet.2015.02.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Lee C, Kim KH, Cohen P. MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic Biol Med. 2016;100:182–187. doi: 10.1016/j.freeradbiomed.2016.05.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metab. 2018;28:516–524. doi: 10.1016/j.cmet.2018.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Mangalhara KC, Shadel GS. A Mitochondrial-Derived Peptide Exercises the Nuclear Option. Cell Metab. 2018;28:330–331. doi: 10.1016/j.cmet.2018.08.017. [DOI] [PubMed] [Google Scholar]
  • 104.Wong W. Going nuclear with stress. Science Signaling. 2018;11:eaav4285. doi: 10.1126/scisignal.aav4285. [DOI] [Google Scholar]
  • 105.Muzumdar RH, Huffman DM, Atzmon G, et al. Humanin: a novel central regulator of peripheral insulin action. PLoS One. 2009;4:e6334. doi: 10.1371/journal.pone.0006334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Lee C, Wan J, Miyazaki B, et al. IGF-I regulates the age-dependent signaling peptide humanin. Aging Cell. 2014;13:958–961. doi: 10.1111/acel.12243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Fuku N, Pareja-Galeano H, Zempo H, et al. The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity? Aging Cell. 2015;14:921–923. doi: 10.1111/acel.12389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Zempo H, Fuku N, Nishida Y, et al. Relation between type 2 diabetes and m. 1382 A> C polymorphism which occurs amino acid replacement (K14Q) of mitochondria-derived MOTS-c. FASEB J. 2016;30:956.1. [Google Scholar]
  • 109.Price NL, Gomes AP, Ling AJ, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012;15:675–690. doi: 10.1016/j.cmet.2012.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Cantó C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009;458:1056–1060. doi: 10.1038/nature07813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Dunham-Snary KJ, Ballinger SW. GENETICS. Mitochondrial-nuclear DNA mismatch matters. Science. 2015;349:1449–1450. doi: 10.1126/science.aac5271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Rand DM. Fishing for adaptive epistasis using mitonuclear interactions. PLoS Genet. 2017;13:e1006662. doi: 10.1371/journal.pgen.1006662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Tranah GJ. Mitochondrial-nuclear epistasis: Implications for human aging and longevity. Ageing Res Rev. 2011;10:238–252. doi: 10.1016/j.arr.2010.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.McManus MJ, Picard M, Chen HW, et al. Mitochondrial DNA Variation Dictates Expressivity and Progression of Nuclear DNA Mutations Causing Cardiomyopathy. Cell Metab. 2018 doi: 10.1016/j.cmet.2018.08.002. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Deuse T, Wang D, Stubbendorff M, et al. SCNT-derived ESCs with mismatched mitochondria trigger an immune response in allogeneic hosts. Cell Stem Cell. 2015;16:33–38. doi: 10.1016/j.stem.2014.11.003. [DOI] [PubMed] [Google Scholar]
  • 116.Betancourt AM, King AL, Fetterman JL, et al. Mitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in mice. Biochemical J. 2014;461:223–232. doi: 10.1042/BJ20131433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Fetterman JL, Zelickson BR, Johnson LW, et al. Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload. Biochemical J. 2013;455:157–167. doi: 10.1042/BJ20130029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Raimundo N, Kriško A. Cross-organelle communication at the core of longevity. Aging. 2018;10:15–16. doi: 10.18632/aging.101373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Rieusset J. The role of endoplasmic reticulum-mitochondria contact sites in the control of glucose homeostasis: an update. Cell Death Dis. 2018;9:388. doi: 10.1038/s41419-018-0416-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Janikiewicz J, Szymański J, Malinska D, et al. Mitochondria-associated membranes in aging and senescence: structure, function, and dynamics. Cell Death Dis. 2018;9:332. doi: 10.1038/s41419-017-0105-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Wang CH, Chen YF, Wu CY, et al. Cisd2 modulates the differentiation and functioning of adipocytes by regulating intracellular Ca2+ homeostasis. Hum Mol Genet. 2014;23:4770–4785. doi: 10.1093/hmg/ddu193. [DOI] [PubMed] [Google Scholar]
  • 122.Chen YF, Kao CH, Chen YT, et al. Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev. 2009;23:1183–1194. doi: 10.1101/gad.1779509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Titorenko VI, Terlecky SR. Peroxisome metabolism and cellular aging. Traffic. 2011;12:252–259. doi: 10.1111/j.1600-0854.2010.01144.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Sebastián D, Palacín M, Zorzano A. Mitochondrial dynamics: coupling mitochondrial fitness with healthy aging. Trends Mol Med. 2017;23:201–215. doi: 10.1016/j.molmed.2017.01.003. [DOI] [PubMed] [Google Scholar]
  • 125.Koepke JI, Nakrieko KA, Wood CS, et al. Restoration of peroxisomal catalase import in a model of human cellular aging. Traffic. 2007;8:1590–1600. doi: 10.1111/j.1600-0854.2007.00633.x. [DOI] [PubMed] [Google Scholar]
  • 126.Santos MJ, Quintanilla RA, Toro A, et al. Peroxisomal proliferation protects from β-amyloid neurodegeneration. J Biol Chem. 2005;280:41057–41068. doi: 10.1074/jbc.M505160200. [DOI] [PubMed] [Google Scholar]
  • 127.Nell HJ, Au JL, Giordano CR, et al. Targeted Antioxidant, Catalase-SKL, Reduces Beta-Amyloid Toxicity in the Rat Brain. Brain Pathol. 2017;27:86–94. doi: 10.1111/bpa.12368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Yoboue ED, Sitia R, Simmen T. Redox crosstalk at endoplasmic reticulum (ER) membrane contact sites (MCS) uses toxic waste to deliver messages. Cell Death Dis. 2018;9:331. doi: 10.1038/s41419-017-0033-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Carmona-Gutierrez D, Hughes AL, Madeo F, Ruckenstuhl C. The crucial impact of lysosomes in aging and longevity. Ageing Res Rev. 2016;32:2–12. doi: 10.1016/j.arr.2016.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Soto-Heredero G, Baixauli F, Mittelbrunn M. Interorganelle communication between mitochondria and the endolysosomal system. Front Cell Dev Biol. 2017;5:95. doi: 10.3389/fcell.2017.00095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Hughes AL, Gottschling DE. An early age increase in vacuolar pH limits mitochondrial function and lifespan in yeast. Nature. 2012;492:261–265. doi: 10.1038/nature11654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Elbaz-Alon Y, Rosenfeld-Gur E, Shinder V, Futerman AH, Geiger T, Schuldiner M. A dynamic interface between vacuoles and mitochondria in yeast. Dev Cell. 2014;30:95–102. doi: 10.1016/j.devcel.2014.06.007. [DOI] [PubMed] [Google Scholar]
  • 133.Klecker T, Westermann B. Mitochondria Are Clamped to Vacuoles for Lipid Transport. Dev Cell. 2014;30:1–2. doi: 10.1016/j.devcel.2014.06.024. [DOI] [PubMed] [Google Scholar]
  • 134.Murley A, Sarsam RD, Toulmay A, Yamada J, Prinz WA, Nunnari J. Ltc1 is an ER-localized sterol transporter and a component of ER-mitochondria and ER-vacuole contacts. J Cell Biol. 2015;209:539–548. doi: 10.1083/jcb.201502033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Hönscher C, Mari M, Auffarth K, et al. Cellular metabolism regulates contact sites between vacuoles and mitochondria. Dev Cell. 2014;30:86–94. doi: 10.1016/j.devcel.2014.06.006. [DOI] [PubMed] [Google Scholar]
  • 136.Durieux J, Wolff S, Dillin A. The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell. 2011;144:79–91. doi: 10.1016/j.cell.2010.12.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Woo DK, Shadel GS. Mitochondrial stress signals revise an old aging theory. Cell. 2011;144:11–12. doi: 10.1016/j.cell.2010.12.023. [DOI] [PubMed] [Google Scholar]
  • 138.Zhang Q, Wu X, Chen P, et al. The mitochondrial unfolded protein response is mediated cell-nonautonomously by retromer-dependent Wnt signaling. Cell. 2018;174:870–883.e817. doi: 10.1016/j.cell.2018.06.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Owusu-Ansah E, Song W, Perrimon N. Muscle mitohormesis promotes longevity via systemic repression of insulin signaling. Cell. 2013;155:699–712. doi: 10.1016/j.cell.2013.09.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Kim KH, Jeong YT, Oh H, et al. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med. 2012;19:83–92. doi: 10.1038/nm.3014. [DOI] [PubMed] [Google Scholar]
  • 141.Berendzen KM, Durieux J, Shao LW, et al. Neuroendocrine coordination of mitochondrial stress signaling and proteostasis. Cell. 2016;166:1553–1563.e1510. doi: 10.1016/j.cell.2016.08.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Shao L-W, Niu R, Liu Y. Neuropeptide signals cell non-autonomous mitochondrial unfolded protein response. Cell Res. 2016;26:1182–1196. doi: 10.1038/cr.2016.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.da Cunha FM, Torelli NQ, Kowaltowski AJ. Mitochondrial Retrograde Signaling: Triggers, Pathways, and Outcomes. Oxid Med Cell Longev. 20152015 doi: 10.1155/2015/482582. 482582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Lee C, Kim KH, Cohen P. MOTS-c: a novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic Biol Med. 2016;100:182–187. doi: 10.1016/j.freeradbiomed.2016.05.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Bachar AR, Scheffer L, Schroeder AS, et al. Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress. Cardiovasc Res. 2010;88:360–366. doi: 10.1093/cvr/cvq191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3:70ra13. doi: 10.1126/scitranslmed.3001845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Cobb LJ, Lee C, Xiao J, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging. 2016;8:796–809. doi: 10.18632/aging.100943. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMB Reports are provided here courtesy of Korean Society for Biochemistry and Molecular Biology

RESOURCES